DK1359943T3 - Biotinderivater og deres konjugater med chelateringsmidler - Google Patents

Biotinderivater og deres konjugater med chelateringsmidler

Info

Publication number
DK1359943T3
DK1359943T3 DK02703851T DK02703851T DK1359943T3 DK 1359943 T3 DK1359943 T3 DK 1359943T3 DK 02703851 T DK02703851 T DK 02703851T DK 02703851 T DK02703851 T DK 02703851T DK 1359943 T3 DK1359943 T3 DK 1359943T3
Authority
DK
Denmark
Prior art keywords
conjugates
chelating agents
biotin derivatives
preparation
therapy
Prior art date
Application number
DK02703851T
Other languages
Danish (da)
English (en)
Inventor
Mauro Ginanneschi
Giovanni Paganelli
Marco Chinol
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1359943T3 publication Critical patent/DK1359943T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
DK02703851T 2001-02-16 2002-02-15 Biotinderivater og deres konjugater med chelateringsmidler DK1359943T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001RM000079A ITRM20010079A1 (it) 2001-02-16 2001-02-16 Amminoderivati della biotina e loro coniugati con chelanti macrociclici.

Publications (1)

Publication Number Publication Date
DK1359943T3 true DK1359943T3 (da) 2006-01-02

Family

ID=11455227

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02703851T DK1359943T3 (da) 2001-02-16 2002-02-15 Biotinderivater og deres konjugater med chelateringsmidler

Country Status (19)

Country Link
US (2) US7390828B2 (fr)
EP (1) EP1359943B1 (fr)
JP (1) JP4469133B2 (fr)
KR (1) KR100860062B1 (fr)
CN (1) CN100457192C (fr)
AT (1) ATE306283T1 (fr)
AU (1) AU2002237517B2 (fr)
BR (1) BR0207327A (fr)
CZ (1) CZ305442B6 (fr)
DE (1) DE60206599T2 (fr)
DK (1) DK1359943T3 (fr)
ES (1) ES2248522T3 (fr)
HK (1) HK1068251A1 (fr)
HU (1) HU229160B1 (fr)
IT (1) ITRM20010079A1 (fr)
MX (1) MXPA03007317A (fr)
PL (1) PL202898B1 (fr)
SK (1) SK286112B6 (fr)
WO (1) WO2002066075A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030196A1 (it) * 2003-04-24 2004-10-25 Sigma Tau Ind Farmaceuti Uso di reagenti per la preparazione di un medicamento
ITRM20040105A1 (it) * 2004-02-27 2004-05-27 Tecnogen Scpa Anticorpo monoclonale antitenascina umana.
ITRM20050345A1 (it) * 2005-06-30 2007-01-01 Sigma Tau Ind Farmaceuti Sintesi di deossi-biotinil esametilen diammina-dota.
TWI381852B (zh) 2005-09-27 2013-01-11 Sigma Tau Ind Farmaceuti 生物素二胺基衍生物類及其與大環螯合劑之共軛物
CA2682296C (fr) 2007-04-04 2017-02-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Anticorps anti-epcam et ses utilisations
GB0922369D0 (en) 2009-12-22 2010-02-03 Hammersmith Imanet Ltd Labelled biotin conjugates
RU2013122898A (ru) * 2010-10-22 2014-11-27 Университы До Страсбур Похоксимовые конъюгаты, применимые для лечения связанных с hsp90 патологий, композиция и способ лечения с их помощью
BR112014002593B1 (pt) 2011-08-02 2022-11-29 Alfasigma S.p.A Composição farmacêutica de avidina oxidada apropriada para inalação e kits relacionados

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416738B1 (en) * 1973-12-07 2002-07-09 Neorx Corporation Pretargeting methods and compounds
US5283342A (en) * 1992-06-09 1994-02-01 Neorx Corporation Biotinylated small molecules
US6075010A (en) * 1992-06-09 2000-06-13 Neorx Corporation Small molecular weight ligand-hexose containing clearing agents
DE3713842A1 (de) * 1987-04-22 1988-11-17 Schering Ag Substituierte cyclische komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
IT1245748B (it) 1990-12-21 1994-10-14 Mini Ricerca Scient Tecnolog Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego
US5914312A (en) * 1992-06-09 1999-06-22 Neorx Corporation Pretargeting methods and compounds
US5578287A (en) * 1992-06-09 1996-11-26 Neorx Corporation Three-step pretargeting methods using improved biotin-active agent
US6358490B2 (en) * 1992-06-09 2002-03-19 Neorx Corporation Three-step pretargeting methods and compounds
US5911969A (en) * 1992-06-09 1999-06-15 Neorx Corporation Pretargeting protocols for enhanced localization of active agents to target sites
US5616690A (en) * 1992-06-09 1997-04-01 Neorx Corporation Hexose derivatized human serum albumin clearing agents
ATE210464T1 (de) * 1992-06-09 2001-12-15 Neorx Corp BIOTIN-DOTA KONJUGATE UND DEREN VERWENDUNG IN ßPRETARGETINGß VERFAHREN
US5624896A (en) * 1992-06-09 1997-04-29 Neorx Corporation Clearing agents useful in pretargeting methods
US5541287A (en) * 1992-06-09 1996-07-30 Neorx Corporation Pretargeting methods and compounds
US5976535A (en) * 1992-06-09 1999-11-02 Neorx Corporation Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
US6217869B1 (en) * 1992-06-09 2001-04-17 Neorx Corporation Pretargeting methods and compounds
US6120768A (en) * 1993-05-17 2000-09-19 Immunomedics, Inc. Dota-biotin derivatives
JPH0730748U (ja) * 1993-11-29 1995-06-13 花王株式会社 歯ブラシ
US5955605A (en) * 1995-02-21 1999-09-21 Neorx Corporation Biotinidase resistant biotin-DOTA conjugates
WO1997010854A1 (fr) * 1995-09-18 1997-03-27 Mallinckrodt Medical, Inc. Composes de biotine (radio) marques
JP3427871B2 (ja) * 1996-06-24 2003-07-22 戸田工業株式会社 コバルト被着型針状磁性酸化鉄粒子粉末
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms

Also Published As

Publication number Publication date
JP4469133B2 (ja) 2010-05-26
JP2004524305A (ja) 2004-08-12
MXPA03007317A (es) 2004-06-30
HK1068251A1 (en) 2005-04-29
CN1531445A (zh) 2004-09-22
SK11152003A3 (sk) 2004-02-03
CZ305442B6 (cs) 2015-09-23
US20040067199A1 (en) 2004-04-08
AU2002237517B2 (en) 2006-11-30
CN100457192C (zh) 2009-02-04
EP1359943A2 (fr) 2003-11-12
ITRM20010079A1 (it) 2002-08-16
ES2248522T3 (es) 2006-03-16
WO2002066075A3 (fr) 2003-01-30
ATE306283T1 (de) 2005-10-15
HUP0303151A3 (en) 2010-01-28
HU229160B1 (hu) 2013-09-30
DE60206599T2 (de) 2006-06-22
BR0207327A (pt) 2004-02-10
DE60206599D1 (de) 2005-11-17
WO2002066075A2 (fr) 2002-08-29
EP1359943B1 (fr) 2005-10-12
PL202898B1 (pl) 2009-08-31
SK286112B6 (sk) 2008-03-05
US8044081B2 (en) 2011-10-25
KR100860062B1 (ko) 2008-09-24
ITRM20010079A0 (it) 2001-02-16
HUP0303151A2 (hu) 2003-12-29
KR20030072627A (ko) 2003-09-15
US20080085239A1 (en) 2008-04-10
CZ20031989A3 (cs) 2004-02-18
PL365279A1 (en) 2004-12-27
US7390828B2 (en) 2008-06-24

Similar Documents

Publication Publication Date Title
NO20044475L (no) 2-(2,6-diklorfenyl)-diarulimidazoler
ATE302775T1 (de) Carbolinderivate
DK1472541T3 (da) Afbildningsmidler og metoder til at afbilde NAALADase og PSMA
DE69912606D1 (de) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivate
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
YU50800A (sh) Derivati 2-(purin-9-il)-tetrahidrofuran-3,4-diola
NO20070782L (no) Tetrapeptidanaloger.
TR200002218T2 (tr) 2-(Pürin-9-il)-Tetrahidrofüran -3,4-Diol türevleri
TR200100410T2 (tr) 2-(purin-9-il)-tetrahidrofuran-3,4-diol türevleri.
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
ATE346067T1 (de) Carbolinderivate
CY1108808T1 (el) Ενωσεις μοτιλιδης
NO20022528D0 (no) Kjemiske derivater og deres anvendelse som anti- telomerasemiddel
HK1068251A1 (en) Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents
MXPA03002911A (es) Compuestos quimicos.
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
TW200744647A (en) Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
TW200504051A (en) Novel acridine derivatives and their use as medicaments
NO20030500D0 (no) Dihydroporfyrinderivater og deres anvendelse
MY140194A (en) Novel fusidic acid derivatives
NO20010626D0 (no) N-substituerte azabicykloheptanderivater, deres fremstilling og anvendelse
TW200510447A (en) Novel fusidic acid derivatives